会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Quinuclidine compounds and drugs containing the same as the active ingredient
    • 奎宁环化合物和含有与活性成分相同的药物
    • US06599917B1
    • 2003-07-29
    • US10088554
    • 2002-03-19
    • Toshimi OkadaNobuyuki KurusuKeigo TanakaKazuki MiyazakiDaisuke ShinmyoHiroyuki SugumiHironori IkutaHironobu HiyoshiTakao SaekiMamoru YanagimachiMasashi Ito
    • Toshimi OkadaNobuyuki KurusuKeigo TanakaKazuki MiyazakiDaisuke ShinmyoHiroyuki SugumiHironori IkutaHironobu HiyoshiTakao SaekiMamoru YanagimachiMasashi Ito
    • A61K31439
    • C07D453/02
    • The present invention provides an excellent squalene synthesizing enzyme inhibitor. Specifically, it provides a compound (I) represented by the following formula, a salt thereof or a hydrate of them. In which R1 represents (1) hydrogen atom or (2) hydroxyl group; HAr represents an aromatic heterocycle which may be substituted with 1 to 3 groups; Ar represents an optionally substituted aromatic ring; W represents a chain represented by (1) —CH2—CH2— which may be substituted, (2) —CH═CH— which may be substituted, (3) —C≡C—, (4) —NH—CO—, (5) —CO—NH—, (6) —NH—CH2—, (7) —CH2—NH—, (8) —CH2—CO—, (9) —CO—CH2—, (10) —NH—S(O)l—, (11) —S(O)l—NH—, (12) —CH2—S(O)— or (13) —S(O)l—CH2— (l denotes 0, 1 or 2); and X represents a chain represented by (1) a single bond, (2) an optionally substituted C1-6 alkylene chain, (3) an optionally substituted C2-6 alkenylene chain, (4) an optionally substituted C2-6 alkynylene chain, (5) a formula —Q— (wherein Q represents oxygen atom, sulfur atom, CO or N(R2) (wherein R2 represents a C1-6 alkyl group or a C1-6 alkoxy group)), (6) —NH—CO—, (7) —CO—NH—, (8) —NH—CH2—, (9) —CH2—NH—, (10) —CH2—CO—, (11) —CO—CH2—, (12) —NH—S(O)m—, (13) —S(O)m—NH—, (14) —CH2—S(O)m—, (15) —S(O)m—CH2— (wherein m denotes 0, 1 or 2) or (16) —(CH2)n—O— (wherein n denotes an integer from 1 to 6).
    • 本发明提供优良的角鲨烯合成酶抑制剂。 具体地说,它提供由下式表示的化合物(I),其盐或它们的水合物。其中R1表示(1)氢原子或(2)羟基; HAr表示可被1〜3个基团取代的芳香族杂环; Ar表示任选取代的芳环; W表示可被取代的(1)-CH 2 -CH 2 - 表示的链,(2)可以被取代的-CH = CH-,(3)-C = C-,(4)-NH-CO-, (5)-CO-NH-,(6)-NH-CH2-,(7)-CH2-NH-,(8)-CH2-CO-,(9)-CO-CH2-,(10)-NH -S(O)1 - ,(11)-S(O)1 -NH-,(12)-CH 2 -S(O) - 或(13)-S(O) 1或2); 并且X表示由(1)单键表示的链,(2)任选取代的C 1-6亚烷基链,(3)任选取代的C 2-6亚烯基链,(4)任选取代的C 2-6亚炔基链, (5)式-Q-(其中Q表示氧原子,硫原子,CO或N(R2)(其中R2表示C1-6烷基或C1-6烷氧基)),(6)-NH- CO-,(7)-CO-NH-,(8)-NH-CH2-,(9)-CH2-NH-,(10)-CH2-CO-,(11)-CO-CH2-, )-NH-S(O)m - ,(13)-S(O)m -NH-,(14)-CH 2 -S(O)m - ,(15)-S(O)m -CH 2 - 其中m表示0,1或2)或(16) - (CH2)nO-(其中n表示1至6的整数)。
    • 7. 发明授权
    • Primary cultured adipocytes for gene therapy
    • 原代培养的脂肪细胞进行基因治疗
    • US08071085B2
    • 2011-12-06
    • US12175186
    • 2008-07-17
    • Masashi ItoYasushi Saito
    • Masashi ItoYasushi Saito
    • A61K48/00C12P21/00C12P21/02
    • C12N5/0653A61K35/12C12N2510/00C12N2510/02
    • The present invention relates to primary cultured adipocytes for gene therapy, where the adipocytes stably maintain a foreign gene encoding a protein that is secreted outside of cells. This invention provides cells suitable for gene therapy, which can replace bone marrow cells and liver cells used for conventional ex vivo gene therapy. The present invention established methods for transferring foreign genes into primary cultured adipocytes, which are suitable for ex vivo gene therapy; can be easily collected and implanted; and can be removed after implantation. Specifically, the present invention established these methods that use retroviral vectors. The present invention also established primary cultured adipocytes for gene therapy, where the adipocytes stably maintain a foreign gene encoding a protein that is secreted outside of cells.
    • 本发明涉及用于基因治疗的原代培养的脂肪细胞,其中脂肪细胞稳定地维持编码在细胞外分泌的蛋白质的外源基因。 本发明提供适用于基因治疗的细胞,其可代替用于常规体外基因治疗的骨髓细胞和肝细胞。 本发明建立了将外源基因转移到适合离体基因治疗的原代培养脂肪细胞中的方法; 可以轻松收集和植入; 并且可以在植入后去除。 具体地,本发明建立了使用逆转录病毒载体的这些方法。 本发明还建立了用于基因治疗的原代培养的脂肪细胞,其中脂肪细胞稳定地保持编码在细胞外分泌的蛋白质的外源基因。
    • 10. 发明申请
    • Method for Manufacturing Optically Active Tetrahydrothiophene Derivative and Method for Crystallization of Optically Active Tetrahydrothiophene-3-Ol
    • 光学活性四氢噻吩衍生物的制备方法和光活性四氢噻吩-3-O的结晶方法
    • US20080050787A1
    • 2008-02-28
    • US10581366
    • 2004-12-01
    • Hazuki NagaiKaname KonukiMasashi ItoTomohiro Sameshima
    • Hazuki NagaiKaname KonukiMasashi ItoTomohiro Sameshima
    • C12P17/00C07D333/32
    • C12P17/167
    • A method for manufacturing (R)-tetrahydrothiophene-3-ol denoted by formula (II): by bioconversion of tetrahydrothiophene-3-one denoted by formula (I): to (R)-tetrahydrothiophene-3-ol denoted by formula (II). It comprises the steps of: (A) incubating the tetrahydrothiophene-3-one denoted by formula (I) in the presence of a strain, or a preparation of a cultured cell thereof, belonging to Penicillium, Aspergillus, or Streptomyces that is capable of said bioconversion; and (B) collecting the (R)-tetrahydrothiophene-3-ol denoted by formula (II) from incubated solution. A method for crystallization of optically active tetrahydrothiophene-3-ol of improved optical purity, characterized by maintaining a solution comprising optically active tetrahydrothiophene-3-ol and organic solvent at equal to or lower than 1° C. to cause optically active tetrahydrothiophene-3-ol to crystallize from said solution, or characterized by adding optically active tetrahydrothiophene-3-ol dropwise to organic solvent at a solution temperature of equal to or lower than 1° C. to cause optically active tetrahydro thiophene-3-ol to crystallize.
    • 由式(II)表示的(R) - 四氢噻吩-3-醇的制造方法:通过式(I)表示的四氢噻吩-3-酮的生物转化:式(II)表示的(R) - 四氢噻吩-3-醇 )。 其包括以下步骤:(A)在菌株存在下将式(I)表示的四氢噻吩-3-酮或其培养细胞的制剂,属于青霉属,曲霉属或链霉菌属,其能够 说生物转化 和(B)从温育溶液中收集由式(II)表示的(R) - 四氢噻吩-3-醇。 一种提高光学纯度的光学活性四氢噻吩-3-醇的结晶方法,其特征在于将含有光学活性四氢噻吩-3-醇和有机溶剂的溶液保持在等于或低于1℃,使光学活性的四氢噻吩-3 - 醇从所述溶液中结晶,或者特征在于在等于或低于1℃的溶液温度下将光学活性的四氢噻吩-3-醇滴加到有机溶剂中,使光学活性的四氢噻吩-3-醇结晶。